DekaBank Deutsche Girozentrale’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-38,500
Closed -$179K 1293
2023
Q1
$179K Hold
38,500
﹤0.01% 1197
2022
Q4
$205K Hold
38,500
﹤0.01% 1216
2022
Q3
$241K Hold
38,500
﹤0.01% 1192
2022
Q2
$186K Buy
+38,500
New +$190K ﹤0.01% 1200
2022
Q1
Sell
-35,000
Closed -$347K 1404
2021
Q4
$347K Buy
+35,000
New +$376K ﹤0.01% 1173

Other funds holding MXCT

DekaBank Deutsche Girozentrale's MXCT Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of MaxCyte (MXCT) in Q2 2023, closing a stake of 38,500 shares — an estimated $179K sold.

DekaBank Deutsche Girozentrale first reported a position in MXCT in Q4 2021 and held it in 5 quarters. The position peaked at $347K in Q4 2021. 116 funds tracked by Wall St. Rank hold MXCT as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining MaxCyte position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 38,500 MaxCyte shares in Q2 2023, an estimated $179K.
  • DekaBank Deutsche Girozentrale first reported a position in MaxCyte in Q4 2021 and held it in 5 quarters.
  • DekaBank Deutsche Girozentrale's MaxCyte position peaked at $347K in Q4 2021.
  • 116 funds tracked by Wall St. Rank held MaxCyte as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.